These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 8786388)
1. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. Maeda A; Sobel RA J Neuropathol Exp Neurol; 1996 Mar; 55(3):300-9. PubMed ID: 8786388 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions. van Horssen J; Vos CM; Admiraal L; van Haastert ES; Montagne L; van der Valk P; de Vries HE Neuropathol Appl Neurobiol; 2006 Dec; 32(6):585-93. PubMed ID: 17083473 [TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Cossins JA; Clements JM; Ford J; Miller KM; Pigott R; Vos W; Van der Valk P; De Groot CJ Acta Neuropathol; 1997 Dec; 94(6):590-8. PubMed ID: 9444361 [TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. Vos CM; van Haastert ES; de Groot CJ; van der Valk P; de Vries HE J Neuroimmunol; 2003 May; 138(1-2):106-14. PubMed ID: 12742660 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system. Toft-Hansen H; Babcock AA; Millward JM; Owens T J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829 [TBL] [Abstract][Full Text] [Related]
6. Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure). de Jong JM; Wang P; Oomkens M; Baron W J Neurosci Res; 2020 Jul; 98(7):1370-1397. PubMed ID: 31965607 [TBL] [Abstract][Full Text] [Related]
7. Neuronal injury in chronic CNS inflammation. Zindler E; Zipp F Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866 [TBL] [Abstract][Full Text] [Related]
8. The extracellular matrix in multiple sclerosis: an update. Sobel RA Braz J Med Biol Res; 2001 May; 34(5):603-9. PubMed ID: 11323746 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis. Gröters S; Alldinger S; Baumgärtner W Acta Neuropathol; 2005 Oct; 110(4):369-82. PubMed ID: 16133545 [TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Leppert D; Lindberg RL; Kappos L; Leib SL Brain Res Brain Res Rev; 2001 Oct; 36(2-3):249-57. PubMed ID: 11690622 [TBL] [Abstract][Full Text] [Related]
13. [Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis]. Kurzepa J; Bartosik-Psujek H; Suchozebrska-Jesionek D; Rejdak K; Stryjecka-Zimmer M; Stelmasiak Z Neurol Neurochir Pol; 2005; 39(1):63-7. PubMed ID: 15735992 [TBL] [Abstract][Full Text] [Related]
14. The extracellular matrix in multiple sclerosis lesions. Sobel RA J Neuropathol Exp Neurol; 1998 Mar; 57(3):205-17. PubMed ID: 9600212 [TBL] [Abstract][Full Text] [Related]
15. An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis. Boziki M; Grigoriadis N Med Chem; 2018 Feb; 14(2):155-169. PubMed ID: 28875862 [TBL] [Abstract][Full Text] [Related]
17. Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment. Liuzzi GM; Latronico T; Fasano A; Carlone G; Riccio P Mult Scler; 2004 Jun; 10(3):290-7. PubMed ID: 15222694 [TBL] [Abstract][Full Text] [Related]
18. Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. Ghorpade A; Persidskaia R; Suryadevara R; Che M; Liu XJ; Persidsky Y; Gendelman HE J Virol; 2001 Jul; 75(14):6572-83. PubMed ID: 11413325 [TBL] [Abstract][Full Text] [Related]
19. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. Djurić T; Zivković M; Stanković A; Dincić E; Raicević R; Alavantić D J Neurol Sci; 2008 Apr; 267(1-2):62-5. PubMed ID: 17942123 [TBL] [Abstract][Full Text] [Related]
20. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Anthony DC; Ferguson B; Matyzak MK; Miller KM; Esiri MM; Perry VH Neuropathol Appl Neurobiol; 1997 Oct; 23(5):406-15. PubMed ID: 9364466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]